Press release
Brachytherapy Devices Market is Projected to Grow at an 8.3% CAGR, Reaching US$ 2,148.3 Million by 2035 | Fact.MR Report
The brachytherapy devices market is expected to be USD 963.8 million in 2025. The market for brachytherapy devices will experience a growth rate of 8.3% CAGR and is expected to be USD 2,148.3 million by 2035. The drivers for this include the growing cases of cancer across the globe, increased applications of targeted radiation therapy, and emerging technologies in minimally invasive cancer therapy.Since cancer remains a leading cause of death worldwide, doctors are increasingly looking to localized and high-precision radiation therapy. Brachytherapy can potentially administer high doses of radiation directly to tumors while minimizing healthy tissues in the immediate vicinity. It is becoming popular in many types of cancer, most significantly prostate, cervical, breast, and skin cancers. The trend toward organ-sparing treatment techniques is also fueling demand.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=5124
Country-Wise Analysis
The USA brachytherapy devices market is expected to grow at 7.9% CAGR between the study periods. As the world leader in cancer care innovations, the USA continues to invest heavily in pioneering therapeutic modalities like brachytherapy.
The UK brachytherapy equipment market will rise at 6.8% CAGR between the forecast years. A well-developed infrastructure for cancer care and growing cases of cancer are key drivers for brachytherapy demand within the UK. The healthcare segment, dominated by the NHS, is showing ever-greater enthusiasm for shorter treatments and better outcomes-clinical goals that have much to favor them with the benefits of brachytherapy. Prostate and gynecological cancer localized treatments have seen increased adoption of brachytherapy solutions.
Germany's market for brachytherapy devices is expected to grow at 6.6% CAGR during the period of study. Germany's leadership in technology regarding device adoption and its cancer research are creating the ideal environment to promote brachytherapy.
The South Korean brachytherapy devices market is expected to register 5.9% CAGR during the study period. Greater focus on early cancer detection, coupled with the technologically equipped healthcare infrastructure, is benefiting the growth of brachytherapy products.
Segment-wise Analysis
By Product Type
The brachytherapy equipment industry is product-type segmented into Brachytherapy Afterloaders and Brachytherapy Applicators, both of which play a vital role in delivering internal radiation therapy. In 2025, Brachytherapy Applicators will account for 52% of the share, with brachytherapy afterloaders predicted to take 48%.
By Dose Rate
The market segmentation of the brachytherapy devices market is High Dose Rate (HDR) and Low Dose Rate (LDR) brachytherapy systems according to the following classifications of dose rates. A patient receives a measurement of the intensity and duration of radiation. HDR is expected to have a share of 58% in 2025 and LDR will have a share of 28%.
Competitive Outlook
The market of brachytherapy devices still needs to be navigated by and is intensely dominated by a very few top manufacturers committed to innovation in treating cancer, such as prostate, breast, gynecological, and skin cancer.
After 2024, there is stiff competition among key players in the brachytherapy devices market, including Varian Medical Systems, Elekta AB, Boston Scientific Corporation, C.R. Bard (BD), and Eckert & Ziegler, all of which continue to make further inroads with advanced radiation delivery systems, well-established clinical networks, and emerging therapy portfolios.
Varian Medical Systems, a Siemens Healthineers company, stays ahead with the delivery of a complete line of high-dose-rate (HDR) and low-dose rate (LDR) brachytherapy systems, the go-to option for cancer centers across the globe.
Elekta AB has lengthened its Oncentra and Flexitron platforms for enhancing usability as well as treatment planning functionality and hence gaining additional institutional contracts within Europe and Asia. Boston Scientific, significantly more of a diversified medical device contender, retains a respectable presence within gynecological and prostate brachytherapy systems backed by physician training programs.
Browse Full Report: https://www.factmr.com/report/5124/brachytherapy-devices-market
Key Players
Boston Scientific Corporation
C.R. Bard, Inc.
CIVCO Medical Instruments Co. Inc.
Cook Medical
Eckert & Ziegler
BEBIG
Elekta AB
Theragenics Corporation
Varian Medical Systems, Inc.
iCAD Inc.
Segmentation
By Product Type:
Brachytherapy Afterloaders
Brachytherapy Applicators
Intercavitary Applicators
Interstitial Applicators
Others
By Dose Rate:
High Dose Rate (HDR) Brachytherapy
Low Dose Rate (LDR) Brachytherapy
Pulse Dose Rate (PDR) Brachytherapy
Others
By Indication:
Prostate Cancer
Breast Cancer
Cervical Cancer
Skin Cancer
Others
By End-user:
Hospitals
Cancer Treatment Centres
Others
By Region:
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Check out More Related Studies Published by Fact.MR:
Pleural Catheters Market
https://www.factmr.com/report/3128/pleural-catheters-market
Medical Radiation Shielding Market
https://www.factmr.com/report/medical-radiation-shielding-market
Patient Blood Management Market
https://www.factmr.com/report/patient-blood-management-market
Hysteroscopy Systems Market
https://www.factmr.com/report/2577/hysteroscopy-systems-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Brachytherapy Devices Market is Projected to Grow at an 8.3% CAGR, Reaching US$ 2,148.3 Million by 2035 | Fact.MR Report here
News-ID: 3987326 • Views: …
More Releases from Fact.MR

Vanilla Extract Industry Analysis in South Asia & Oceania Growth to Reach US$ 91 …
The Revenue of vanilla extract industry in South Asia & Oceania is expected to grow from US$ 433.7 million in 2024 to US$ 910.64 million by 2034, at a 7.7% CAGR.
Vanilla orchids, which produce vanilla beans, are cultivated primarily in tropical areas with specific soil and environmental conditions. Tahiti, Madagascar, and Comoros are some of the key areas that produce most of the world's vanilla.
For More Insights into the Market,…

Air Treatment Product Market Size Expected to Reach US$ 166.21 Billion by 2034: …
The size of the global air treatment products market has been estimated to grow to US$ 62.36 billion in 2024 and reach US$ 166.21 billion by the end of 2034. Demand for air treatment products at the global level is anticipated to grow at a healthy CAGR of 10.3% during 2024-2034.
Air treatment products is a group of products and equipment that aim to enhance or sustain the indoor air quality.…

Newborn Metabolic Screening Market is Predicted to Reach US$ 857.4 Billion by 20 …
The size of the newborn metabolic screening market is expected to reach US$ 355.1 million in 2024. A high compound annual growth rate (CAGR) of 9.2% is expected to drive the market through 2034. This upward trend is estimated to drive the market to a high value of US$ 857.4 million by 2034.
As knowledge of metabolic disorders that impact infants has increased, so too has the use of newborn metabolic…

Neuropathic Pain Market Size Worth US$ 14,538.7 Million by 2034 at a CAGR of 5.7 …
The size of the neuropathic pain market was approximately US$ 6,316.6 million in 2019. The net value of the neuropathic drugs to be retailed together with the nerve pain relief services is expected to be approximately US$ 8,382.9 million in 2024. The demand for the neuropathic pain relief medicines and services globally is expected to experience a CAGR of 5.7% during 2034. The industry is expected to be valued at…
More Releases for Brachytherapy
Brachytherapy Afterloaders, Brachytherapy Seeds market global outlook and foreca …
The report gives a complete investigation of the Brachytherapy Afterloaders, Brachytherapy Seeds industry and key market improvements. The exploration record comprises of past and figure showcase data, prerequisite, territories of use, value strategies, and friends portions of the main organizations by topographical district. The Brachytherapy Afterloaders, Brachytherapy Seeds report separates the market size, by volume and worth, depending upon the kind of utilization and area. With everything taken…
Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Research Report
This report studies the global Brachytherapy Afterloaders, Brachytherapy Seeds market status and forecast, categorizes the global Brachytherapy Afterloaders, Brachytherapy Seeds market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Elekta Theragenics Eckert & Ziegler Oncura GE Healthcare Varian BARD Team Best IsoAid…
Brachytherapy Devices Market - Rise in Acceptance of Epimacular Brachytherapy to …
The global brachytherapy devices market is driven by increase in incidence of cancer, high prevalence of cervical & lung cancer in developing regions, developed health care infrastructure, rise in demand for brachytherapy treatment, supportive government initiatives, and high acceptance of minimal invasive surgeries. However, higher reimbursement rates of other advanced radiation therapies, such as, IMRT and proton therapy and increase in demand for robotic prostatectomies are restraining the global brachytherapy…
Brachytherapy Market | Trends, Outlook, 2025
Rising prevalence of prostate cancer is expected to boost growth of the brachytherapy market
Rising number of prostate cancer cases are majorly driving growth of the brachytherapy market. According to the American Cancer Society, as of 2017, around 161,370 people are estimated to be diagnosed with prostate cancer and around 26,730 deaths are recorded due to prostate cancer in the U.S. Prostate cancer is the third-leading cause of death for men…
Asia-Pacific Brachytherapy Afterloaders, Brachytherapy Seeds Market Report 2017 …
Albany, New York, June 30, 2017 : Recent research and the current scenario as well as future market potential of " Asia-Pacific Brachytherapy Afterloaders, Brachytherapy Seeds Industry : Market Overview, Size, Share and Trends 2017 " globally.
In this report, the Asia-Pacific Brachytherapy Afterloaders, Brachytherapy Seeds market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a…
Brachytherapy Afterloaders, Brachytherapy Seeds Market - Global Industry Analysi …
ReportBazzar has released its latest research-based report entitled ‘Brachytherapy Afterloaders, Brachytherapy Seeds’ market. This report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Brachytherapy Afterloaders, Brachytherapy Seeds market. The report also provides a detailed analysis of key trends and latest technologies, playing a prominent role in the Brachytherapy Afterloaders, Brachytherapy Seeds market growth. It takes into account…